Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

3 terminated/withdrawn out of 165 trials

Success Rate

98.1%

+11.6% vs industry average

Late-Stage Pipeline

4%

7 trials in Phase 3/4

Results Transparency

2%

3 of 157 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
152(92.7%)
Phase 3
6(3.7%)
Phase 2
3(1.8%)
Early Phase 1
2(1.2%)
Phase 4
1(0.6%)
164Total
Phase 1(152)
Phase 3(6)
Phase 2(3)
Early Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (165)

Showing 20 of 165 trials
NCT06672016Phase 3Active Not Recruiting

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Role: lead

NCT01733082Recruiting

The Mycophenolate Pregnancy Registry

Role: collaborator

NCT07365904Phase 2Recruiting

Investigating Ovulation Inhibition for Use as a Contraceptive

Role: lead

NCT01320345Phase 3Active Not Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Role: collaborator

NCT04315558Phase 2Completed

Revefenacin in Acute Respiratory Insufficiency in COPD

Role: collaborator

NCT06048536Phase 2Completed

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Role: lead

NCT00650065Phase 1Completed

Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg

Role: lead

NCT00648947Phase 1Completed

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Role: lead

NCT00647738Phase 1Completed

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

Role: lead

NCT00649402Phase 1Completed

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Role: lead

NCT00648557Phase 1Completed

Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg

Role: lead

NCT00650299Phase 1Completed

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

Role: lead

NCT00649012Phase 1Completed

Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg

Role: lead

NCT00650221Phase 1Completed

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

Role: lead

NCT00648427Phase 1Completed

Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

Role: lead

NCT00647894Phase 1Completed

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Role: lead

NCT00647959Phase 1Completed

Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg

Role: lead

NCT00649168Phase 1Completed

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

Role: lead

NCT00648362Phase 1Completed

Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Role: lead

NCT00650533Phase 1Completed

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Role: lead